rs16948767

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000088.4(COL1A1):​c.642+18A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.039 in 1,613,074 control chromosomes in the GnomAD database, including 5,595 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 2628 hom., cov: 31)
Exomes 𝑓: 0.031 ( 2967 hom. )

Consequence

COL1A1
NM_000088.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.760

Publications

6 publications found
Variant links:
Genes affected
COL1A1 (HGNC:2197): (collagen type I alpha 1 chain) This gene encodes the pro-alpha1 chains of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease and idiopathic osteoporosis. Reciprocal translocations between chromosomes 17 and 22, where this gene and the gene for platelet-derived growth factor beta are located, are associated with a particular type of skin tumor called dermatofibrosarcoma protuberans, resulting from unregulated expression of the growth factor. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]
COL1A1 Gene-Disease associations (from GenCC):
  • Caffey disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Ambry Genetics
  • COL1A1-related Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1
    Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: ClinGen, Ambry Genetics
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, arthrochalasia type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • osteogenesis imperfecta
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • osteogenesis imperfecta type 1
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • osteogenesis imperfecta type 2
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • osteogenesis imperfecta type 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • osteogenesis imperfecta type 4
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet
  • Ehlers-Danlos syndrome, classic type, 1
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ehlers-Danlos/osteogenesis imperfecta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • high bone mass osteogenesis imperfecta
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 17-50197931-T-G is Benign according to our data. Variant chr17-50197931-T-G is described in ClinVar as Benign. ClinVar VariationId is 254950.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.346 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000088.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL1A1
NM_000088.4
MANE Select
c.642+18A>C
intron
N/ANP_000079.2P02452

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL1A1
ENST00000225964.10
TSL:1 MANE Select
c.642+18A>C
intron
N/AENSP00000225964.6P02452
COL1A1
ENST00000861334.1
c.642+18A>C
intron
N/AENSP00000531393.1
COL1A1
ENST00000861339.1
c.642+18A>C
intron
N/AENSP00000531398.1

Frequencies

GnomAD3 genomes
AF:
0.115
AC:
17408
AN:
151992
Hom.:
2617
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.351
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0474
Gnomad ASJ
AF:
0.0276
Gnomad EAS
AF:
0.00943
Gnomad SAS
AF:
0.0572
Gnomad FIN
AF:
0.0130
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.0213
Gnomad OTH
AF:
0.0831
GnomAD2 exomes
AF:
0.0476
AC:
11935
AN:
250590
AF XY:
0.0435
show subpopulations
Gnomad AFR exome
AF:
0.358
Gnomad AMR exome
AF:
0.0276
Gnomad ASJ exome
AF:
0.0223
Gnomad EAS exome
AF:
0.00625
Gnomad FIN exome
AF:
0.0141
Gnomad NFE exome
AF:
0.0235
Gnomad OTH exome
AF:
0.0343
GnomAD4 exome
AF:
0.0312
AC:
45538
AN:
1460964
Hom.:
2967
Cov.:
32
AF XY:
0.0313
AC XY:
22757
AN XY:
726896
show subpopulations
African (AFR)
AF:
0.364
AC:
12169
AN:
33426
American (AMR)
AF:
0.0297
AC:
1328
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0217
AC:
568
AN:
26132
East Asian (EAS)
AF:
0.00642
AC:
255
AN:
39694
South Asian (SAS)
AF:
0.0594
AC:
5126
AN:
86234
European-Finnish (FIN)
AF:
0.0148
AC:
789
AN:
53410
Middle Eastern (MID)
AF:
0.0550
AC:
317
AN:
5764
European-Non Finnish (NFE)
AF:
0.0200
AC:
22211
AN:
1111236
Other (OTH)
AF:
0.0460
AC:
2775
AN:
60352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
2015
4029
6044
8058
10073
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
984
1968
2952
3936
4920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.115
AC:
17446
AN:
152110
Hom.:
2628
Cov.:
31
AF XY:
0.112
AC XY:
8317
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.351
AC:
14525
AN:
41410
American (AMR)
AF:
0.0472
AC:
722
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0276
AC:
96
AN:
3472
East Asian (EAS)
AF:
0.00926
AC:
48
AN:
5182
South Asian (SAS)
AF:
0.0568
AC:
274
AN:
4822
European-Finnish (FIN)
AF:
0.0130
AC:
138
AN:
10602
Middle Eastern (MID)
AF:
0.0714
AC:
21
AN:
294
European-Non Finnish (NFE)
AF:
0.0213
AC:
1446
AN:
68004
Other (OTH)
AF:
0.0822
AC:
174
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
618
1237
1855
2474
3092
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
158
316
474
632
790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0465
Hom.:
1003
Bravo
AF:
0.127
Asia WGS
AF:
0.0510
AC:
176
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not specified (2)
-
-
1
not provided (1)
-
-
1
Osteogenesis imperfecta type I (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
5.0
DANN
Benign
0.57
PhyloP100
-0.76
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16948767; hg19: chr17-48275292; COSMIC: COSV56806394; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.